Skip to main content
. Author manuscript; available in PMC: 2014 Oct 30.
Published in final edited form as: Am J Hematol. 2013 May 30;88(8):642–646. doi: 10.1002/ajh.23462

Table 1. Patient Demographic Information.

Baseline Patient Characteristics n (%)
 Age at Diagnosis (median 67, range 60-87) 97 (100%)

Gender

 Male 50 (51.5%)
 Female 47 (48.5%)

Race/Ethnicity

 White 86 (88.7%)
 Black 2 (2.1%)
 Hispanic 3 (3.1%)
 Asian 1 (1%)
 Other 5 (5.2%)

Cardiac Comorbidities

 Coronary Artery Disease 17 (17.5%)
 Diabetes 20 (20.6%)

Patient Body Mass Index

 Normal (< 25) 33 (34%)
 Overweight (≥ 25 & < 30) 33 (34%)
 Obese (≥ 30) 31 (32%)

Performance Status (documented at presentation)

 0 14 (14.4%)
 1 29 (29.9%)
 2 10 (10.3%)
 3 2 (2.1%)
 Missing 42 (43.3%)

De novo or Secondary Disease

 De novo 40 (41.2%)
 Secondary 57 (58.8%)

Patient Cytogenetics

 Favorable 1 (1.0%)
 Intermediate 10 (10.3%)
 Normal karyotype 35 (36.1%)
 Adverse 41 (42.3%)
 Missing 10 (10.3%)

Presenting Laboratories Median (range)

 Total Bilirubin (mg/dl) 0.6 (0.2-4.4)
 Fibrinogen (mg/dl) 459 (100-897)
 Hematocrit (%) 26 (15.7-42.3)
 Platelet Count (th/cumm) 57 (9-953)
 Sodium (mmol/L) 138 (125-144)
 Creatinine (mg/dl) 1 (0.5-4.8)
 Glucose (mg/dl) 109 (77-300)
 Albumin (g/dl) 3.8 (2.4-4.6)